IPH4102 in relapsed/refractory cutaneous T cell lymphoma (CTCL): Results of the first-in-human multicenter phase 1 study-MedSci.cn

IPH4102 in relapsed/refractory cutaneous T cell lymphoma (CTCL): Results of the first-in-human multicenter phase 1 study

Bagot, M; Porcu, P; William, B; Vermeer, M; Whittaker, S; Wolff, CR; Khodadoust, M; Battistella, M; Paiva, C; Sicard, H; Azim, H; Kim, Y

EUROPEAN JOURNAL OF CANCER, 2018; 101 (): S29

科室
- - 订阅+
  - 更多科室
工具
服务